You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR SKLICE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for sklice

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03257943 ↗	A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%	Completed	Taro Pharmaceuticals USA	Phase 1	2017-03-20	A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-group study, comparing Ivermectin Lotion, 0.5%
NCT03301649 ↗	Clinical Endpoint Study of Ivermectin 0.5% Lotion	Completed	Teva Pharmaceuticals USA	Phase 3	2017-10-07	This clinical study is designed to evaluate the clinical (therapeutic) effect of a generic ivermectin lotion 0.5% (Actavis Laboratories UT, Inc.) relative to that of the Food and Drug Administration (FDA) Reference Listed Drug (RLD) SKLICE® (ivermectin) lotion, 0.5% (Arbor Pharmaceuticals, LLC) in participants with active head lice infestation. Additionally, both the test and reference (that is; the RLD) treatments were tested for superiority to a placebo.
NCT03301649 ↗	Clinical Endpoint Study of Ivermectin 0.5% Lotion	Completed	Actavis Inc.	Phase 3	2017-10-07	This clinical study is designed to evaluate the clinical (therapeutic) effect of a generic ivermectin lotion 0.5% (Actavis Laboratories UT, Inc.) relative to that of the Food and Drug Administration (FDA) Reference Listed Drug (RLD) SKLICE® (ivermectin) lotion, 0.5% (Arbor Pharmaceuticals, LLC) in participants with active head lice infestation. Additionally, both the test and reference (that is; the RLD) treatments were tested for superiority to a placebo.
NCT03337490 ↗	A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice	Completed	bioRASI, LLC	Phase 3	2017-10-02	This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.
NCT03337490 ↗	A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice	Completed	Mayne Pharma International Pty Ltd	Phase 3	2017-10-02	This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for sklice

Condition Name

Chart
Table

Condition Name for sklice
Intervention	Trials
Head Lice	2
SARS-CoV 2	1
Anatomic Stage IV Breast Cancer AJCC v8	1
COVID-19	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for sklice
Intervention	Trials
Lice Infestations	3
COVID-19	1
Triple Negative Breast Neoplasms	1
Breast Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for sklice

Trials by Country

Map
Table

Trials by Country for sklice
Location	Trials
United States	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for sklice
Location	Trials
California	2
Florida	2
Maryland	1
Washington	1
Tennessee	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for sklice

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for sklice
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	2
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for sklice
Clinical Trial Phase	Trials
Completed	3
Withdrawn	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sklice

Sponsor Name

Chart
Table

Sponsor Name for sklice
Sponsor	Trials
bioRASI, LLC	2
Taro Pharmaceuticals USA	1
Teva Pharmaceuticals USA	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for sklice
Sponsor	Trials
Industry	6
Other	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.